Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy

Fig. 1

a Cumulative incidence of grade ≥ 2 RP in patients with different involvement volumes of subclinical ILD; b Cumulative incidence of grade ≥ 3 RP in patients with different involvement volumes of subclinical ILD; c Cumulative incidence of grade ≥ 2 RP in patients who had (solid line) or had not (dashed line) received chemotherapy with gemcitabine in the past; d Cumulative incidence of grade ≥ 3 RP in patients who had (solid line) or had not (dashed line) received chemotherapy with gemcitabine in the past

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us